Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",40144,155,1.49 [1.29-1.72],1.0643024919890361e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,40347,156,2.24 [1.86-2.70],1.8357024047558442e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,41264,163,2.05 [1.50-2.81],6.36047835874635e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,41078,162,1.71 [1.40-2.08],9.478398845329142e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,41546,162,1.79 [1.28-2.48],0.000569890224966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,40837,159,2.77 [2.12-3.62],6.991116925985415e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40347,156,2.31 [1.48-3.62],0.0002538244598515
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35570,141,2.83 [1.87-4.27],7.577116892495288e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,35730,144,4.24 [3.04-5.92],2.2541723823421977e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,40704,155,2.42 [1.62-3.60],1.4056713938971178e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,34959,138,2.09 [1.43-3.06],0.0001304306638592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35570,141,2.19 [1.71-2.79],3.637919478537764e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41246,167,3.51 [2.29-5.39],8.283427119160919e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41381,163,3.06 [2.38-3.92],1.936172972939949e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,40885,161,1.77 [1.56-2.00],6.323255257621684e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,41246,167,2.41 [1.73-3.36],2.359463412239636e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,41078,162,1.60 [1.37-1.86],3.901614371210991e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,34769,139,1.50 [1.24-1.80],1.9540197499495934e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,34698,142,1.52 [1.28-1.80],1.5285173560444173e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41580,165,13.39 [7.53-23.81],1.0172448655367297e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,41086,162,1.64 [1.33-2.03],3.981445526065747e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,34959,138,1.95 [1.34-2.83],0.0004515912882699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,41451,161,2.28 [1.65-3.16],7.581362665365578e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,40494,160,2.80 [1.77-4.43],1.0907463714646572e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,41111,167,2.14 [1.55-2.97],4.668705886694308e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,41186,167,1.83 [1.35-2.48],9.7637244319685e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,41451,161,2.05 [1.46-2.88],3.242969059176927e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,41163,162,2.72 [1.82-4.09],1.2800303199139022e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,41229,162,2.30 [1.47-3.59],0.0002571807040184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,35452,143,0.38 [0.25-0.57],3.010855759981643e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,35709,144,0.44 [0.28-0.69],0.0003376832697738
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,34155,140,0.36 [0.22-0.61],0.0001077169024068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,35749,144,0.45 [0.36-0.57],1.315283572544654e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,41168,160,0.49 [0.35-0.67],7.523332788454723e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,40885,161,2.25 [1.76-2.87],9.803239860931863e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,41229,162,2.27 [1.43-3.61],0.0005319375024247
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",41246,167,2.38 [1.49-3.80],0.000297675227781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40144,155,1.71 [1.44-2.03],5.764020542688852e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,41086,162,4.95 [3.37-7.29],4.533552985822149e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,35080,142,0.47 [0.35-0.65],2.1014882233894885e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,34959,138,3.24 [2.05-5.11],4.843322470754515e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,41473,162,3.12 [1.63-5.95],0.0005773707399733
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,41438,159,2.23 [1.93-2.58],4.840256710089172e-27
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,34474,136,1.26 [1.13-1.42],5.641679872226575e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,41246,167,2.51 [1.58-3.97],9.317377130767506e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,41034,163,1.78 [1.31-2.41],0.0002034623993976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,40116,153,1.37 [1.17-1.61],0.0001199365374864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41229,162,2.04 [1.59-2.60],1.3124101641505572e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,34959,138,2.50 [1.62-3.85],3.284505761310529e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35669,140,1.93 [1.41-2.63],3.6699911316540537e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,34922,142,5.36 [3.56-8.08],1.040478704199377e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,40885,161,2.00 [1.38-2.91],0.0002783852125697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",40347,156,1.36 [1.18-1.55],1.171025275262316e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,40956,162,0.66 [0.53-0.82],0.000164987744877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,41451,161,2.08 [1.63-2.64],2.227649222620412e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,34777,137,1.70 [1.35-2.15],6.223167566349424e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,41580,165,1.91 [1.45-2.51],3.649049304013748e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,41546,162,1.30 [1.15-1.46],2.809515191350003e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,41246,167,1.56 [1.24-1.96],0.0001587743584448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,41509,164,2.11 [1.47-3.01],4.2443051693921706e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,40239,158,1.69 [1.25-2.29],0.000717917390888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,41229,162,2.41 [1.82-3.19],7.476547556128965e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,41546,162,1.75 [1.29-2.39],0.0003578659719321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,41193,165,1.84 [1.36-2.51],9.510350875090744e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,40774,156,2.00 [1.41-2.83],0.0001008026840923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40144,155,1.95 [1.54-2.47],3.560461970484987e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,41438,159,2.28 [1.58-3.28],1.1054636849548118e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,40885,161,2.20 [1.48-3.28],9.77102246781088e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41186,167,3.70 [2.43-5.65],1.330509079948173e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,35592,143,1.77 [1.28-2.45],0.0006119462054154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,34959,138,2.09 [1.50-2.90],1.2409752241044284e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41438,159,2.95 [2.08-4.20],1.4443823227994242e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,41546,162,2.05 [1.55-2.70],4.553342268379415e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35725,144,4.18 [2.98-5.86],1.3269372658132583e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,41034,163,2.27 [1.57-3.27],1.2711977829617648e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,35570,141,2.53 [1.52-4.21],0.0003756772367162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,39518,153,2.05 [1.35-3.12],0.0008179599096983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,40774,156,1.85 [1.48-2.32],6.761162157683793e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,39693,155,1.66 [1.28-2.15],0.0001141245213081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,41078,162,1.50 [1.25-1.80],1.267673599354328e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,41078,162,2.74 [1.91-3.93],4.170053099225718e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,41580,165,2.22 [1.46-3.36],0.0001785086218728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,41078,162,2.81 [2.13-3.72],4.2799493229036854e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,40885,161,1.87 [1.53-2.30],1.2119725178558411e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41128,165,8.14 [4.81-13.80],6.5647722335724986e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35570,141,0.70 [0.58-0.86],0.0005206692534488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,41167,162,1.39 [1.20-1.60],7.752721573011303e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,35283,142,0.51 [0.40-0.65],4.111448291929966e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35655,142,1.98 [1.52-2.58],3.356546024718194e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,35559,140,2.00 [1.39-2.88],0.0001894409756508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,40174,157,1.57 [1.36-1.81],9.019901881563055e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,41186,167,2.72 [1.80-4.10],1.7638854924545575e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,41078,162,1.64 [1.26-2.13],0.0002514249272923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41346,161,2.79 [2.03-3.82],1.7277393685189582e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,41546,162,2.56 [2.02-3.26],1.7765185448113282e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,35655,142,2.54 [1.74-3.69],1.28471171044666e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,41229,162,0.51 [0.40-0.65],6.774256170463654e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,41034,163,2.20 [1.66-2.91],3.4719199667022473e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,41580,165,3.11 [1.87-5.16],1.179599654301763e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41078,162,3.28 [2.50-4.30],7.365336678047723e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,34959,138,3.01 [2.42-3.73],1.2543295389770248e-23
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,41580,165,2.15 [1.53-3.01],8.432946094984702e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34777,137,1.91 [1.56-2.35],6.445308766901479e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,41241,155,2.19 [1.50-3.20],5.030946176231303e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,41388,161,2.03 [1.42-2.90],0.0001022458748524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35611,143,3.08 [2.05-4.63],6.84679185849363e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,41229,162,1.85 [1.39-2.46],2.194887275242892e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,40539,163,1.98 [1.46-2.68],1.0500331149911111e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,41246,167,8.54 [5.09-14.35],5.204178517709242e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,40774,156,1.62 [1.23-2.13],0.0006280066262415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41246,167,3.47 [2.22-5.43],5.030302520679543e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35749,144,2.55 [1.91-3.41],2.867462329044241e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,41102,162,1.57 [1.23-2.00],0.0002690893430358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,38371,152,2.31 [1.89-2.84],9.033823171573656e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,41078,162,2.99 [1.78-5.01],3.1880609478472993e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,41546,162,2.42 [1.63-3.58],1.0456084828647222e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,41092,162,2.85 [1.90-4.28],4.17896677870591e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,41034,163,2.01 [1.63-2.49],1.1718765210213163e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,40795,160,1.54 [1.37-1.74],5.632535588858907e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,41078,162,2.10 [1.37-3.22],0.0007016021960227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,41438,159,5.47 [3.51-8.53],6.105716354467683e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,34959,138,2.04 [1.34-3.13],0.0009787901322392
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,41580,165,3.12 [2.00-4.85],4.446681889338166e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,41193,165,2.81 [1.86-4.24],8.292602195423911e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,41034,163,3.13 [2.49-3.95],3.143026321226611e-22
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40611,161,2.46 [1.79-3.37],2.6743687521820547e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,35493,140,1.76 [1.29-2.41],0.0004135293980007
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,41389,161,2.37 [1.56-3.59],4.651920356403659e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35725,144,1.51 [1.27-1.78],2.227067830104512e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41451,161,2.57 [1.89-3.50],2.137017347131621e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41160,162,3.01 [2.02-4.49],5.8059817827337184e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,40704,155,2.36 [1.59-3.53],2.387492554191268e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,41580,165,0.38 [0.22-0.66],0.0005511183637409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,41580,165,8.48 [4.82-14.91],1.1122762981376937e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41580,165,5.95 [4.06-8.71],4.526248309514181e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39797,157,1.65 [1.40-1.95],2.8050023879739723e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40144,155,2.10 [1.73-2.55],8.450758020118985e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39628,157,2.67 [2.05-3.49],4.486381051372274e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,41580,165,3.33 [2.10-5.29],3.319365076394062e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41389,161,2.91 [2.01-4.22],1.7213595606398846e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,41193,165,3.48 [2.03-5.97],6.110213333563905e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,41047,167,2.47 [1.68-3.62],4.06241581999092e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,35749,144,0.36 [0.23-0.58],2.49519779170948e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,35265,143,0.49 [0.35-0.70],7.624546926645061e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",41047,167,1.35 [1.18-1.53],9.971232193790543e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,41451,164,1.70 [1.33-2.15],1.5017773782050636e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,35730,144,3.19 [2.06-4.92],1.6932854269714586e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35725,144,1.74 [1.42-2.13],8.58796710894745e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,40890,160,0.47 [0.38-0.59],7.758475523746103e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,41078,162,1.68 [1.26-2.25],0.0004475269522429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,40144,155,1.40 [1.17-1.67],0.0002445599117883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,41193,165,0.50 [0.34-0.74],0.0004626035562447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,41193,165,7.29 [4.62-11.49],1.2238527846403109e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,41438,159,2.83 [1.81-4.43],4.677971292550207e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,34777,137,3.51 [2.06-5.98],4.075118279413221e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,40983,166,3.79 [2.71-5.30],7.245135460685682e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,34959,138,1.63 [1.30-2.03],1.9841356574673324e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41438,159,2.17 [1.64-2.86],5.30037602505529e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40885,161,2.40 [1.50-3.84],0.0002677244299178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41451,161,2.40 [1.43-4.01],0.000872000022922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,41312,163,4.33 [2.55-7.34],5.6295356462760215e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34112,132,1.57 [1.23-2.00],0.0002743462815603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41580,165,2.39 [2.03-2.81],1.4839506965747216e-25
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,40116,153,1.84 [1.35-2.52],0.0001368035609178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,41021,162,2.39 [1.97-2.90],6.04759596065162e-19
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,40774,156,3.00 [1.90-4.73],2.440747427779969e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,35655,142,2.27 [1.46-3.52],0.0002524646743605
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,41438,159,2.33 [1.51-3.60],0.0001341841081819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",35730,144,1.93 [1.52-2.45],8.256888219721379e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,35559,140,1.79 [1.54-2.08],4.51631658501716e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,40889,161,3.87 [2.36-6.35],8.891252608395151e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",40885,161,1.82 [1.53-2.16],1.6950155693030664e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,41014,162,1.34 [1.15-1.55],0.000128916333245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,41451,161,1.33 [1.20-1.47],2.9582967342496783e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,41392,161,2.01 [1.68-2.41],1.6900859487824868e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41086,162,2.95 [2.13-4.08],7.080631503661554e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,34959,138,4.36 [2.46-7.72],4.534220265341977e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,41546,162,3.78 [2.87-4.96],1.4547499845787448e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35585,142,1.66 [1.39-1.98],2.0294405853103053e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,40116,153,1.66 [1.35-2.04],1.690255336986072e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,40569,153,1.72 [1.30-2.27],0.0001411833930291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40768,158,2.19 [1.40-3.44],0.0006296361794865
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,40903,159,3.85 [2.70-5.50],1.2155680861695194e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,41580,165,2.11 [1.37-3.27],0.0007495255245915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,41580,165,2.82 [1.70-4.66],5.455032328495496e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34725,139,2.16 [1.53-3.06],1.2326409312402472e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,41246,167,3.14 [2.04-4.83],1.7360602415606689e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,40116,153,1.80 [1.40-2.31],3.606781410592608e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,41229,162,0.39 [0.30-0.51],6.6804617068107416e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,41580,165,3.34 [2.81-3.97],2.1487455376812282e-42
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,41078,162,3.27 [2.39-4.46],9.524033945421649e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,40885,161,3.30 [2.65-4.11],1.7866817879073366e-26
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,35725,144,1.37 [1.15-1.63],0.0004134606718535
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41246,167,2.61 [1.95-3.48],6.973981220404248e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,40885,161,1.38 [1.17-1.63],0.0001613855034898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,41546,162,1.58 [1.23-2.02],0.0003263859247128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41229,162,3.49 [2.50-4.89],2.7989813174423535e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,41546,162,2.98 [2.03-4.38],2.911868156248809e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,41021,162,4.29 [2.76-6.68],1.0705255543362951e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,40988,166,3.40 [1.69-6.83],0.0005865387260211
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,41451,164,2.20 [1.63-2.96],2.665413126615953e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,40981,166,1.53 [1.26-1.86],2.1380183635882693e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,40793,163,2.18 [1.62-2.94],2.567099449448504e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,41034,163,2.10 [1.68-2.63],5.3064932630446715e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,41034,163,2.82 [2.13-3.73],4.717860376917227e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,40885,161,1.29 [1.12-1.48],0.0004586493357598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,41078,162,4.66 [2.84-7.65],1.1376261989356278e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,35559,140,1.63 [1.26-2.10],0.0001784548264254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,41086,162,5.94 [3.76-9.41],2.7475737126854145e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,41034,160,2.79 [1.67-4.64],8.108583835649021e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,40838,159,3.09 [2.14-4.48],2.2764892503031923e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,41451,161,1.92 [1.48-2.49],1.091955103867137e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,35730,144,4.09 [3.22-5.18],3.8054903103152e-31
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40885,161,1.74 [1.25-2.42],0.0009834425995278
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,34978,141,1.64 [1.29-2.09],6.627445970115934e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,41193,165,0.45 [0.28-0.72],0.0009874985151096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,40116,153,2.03 [1.38-3.00],0.00035542539016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,40116,153,1.62 [1.22-2.14],0.00075689099602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,41078,162,0.40 [0.29-0.56],1.0629972626275796e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,40149,159,0.57 [0.42-0.78],0.0004082918154104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,35063,142,0.49 [0.33-0.74],0.0005962001479295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,41546,162,2.00 [1.43-2.81],5.7353909485357175e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",40885,161,1.56 [1.37-1.78],6.630378971079566e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",40970,163,1.49 [1.24-1.79],1.8372196065685463e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",34626,133,1.44 [1.29-1.61],1.29969883885403e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,40885,161,2.00 [1.57-2.56],2.598076361327512e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41047,167,1.79 [1.34-2.38],8.152746997256234e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,40697,155,2.04 [1.43-2.90],7.525501023572951e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,35749,144,0.41 [0.28-0.60],3.715577215962883e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,35778,144,2.49 [1.90-3.26],4.187753905458352e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,41047,167,1.79 [1.44-2.21],1.374562092887179e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,41059,166,2.92 [1.98-4.29],5.7549426864483584e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,41034,163,3.59 [2.29-5.63],2.7114125603595494e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41580,165,2.30 [1.40-3.77],0.0009755268835352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41381,163,2.32 [1.53-3.52],8.28239464578107e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,40885,161,1.69 [1.27-2.24],0.0002667210075341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41580,165,4.84 [3.45-6.77],4.296088308207163e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,40852,166,3.07 [2.07-4.56],2.565668240427656e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,41034,163,2.14 [1.46-3.13],8.841088591252763e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,40626,156,3.20 [2.02-5.06],6.518754792690641e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,35725,144,2.07 [1.36-3.14],0.0006766093861728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,41119,167,2.55 [1.62-3.99],4.576964592478593e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,34959,138,0.31 [0.20-0.48],1.356942549204758e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,34959,138,3.23 [2.01-5.20],1.3896356105549546e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,40341,157,1.59 [1.22-2.06],0.0005017048446737
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,40885,161,1.72 [1.48-2.00],1.839060697204754e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,40992,166,1.45 [1.17-1.80],0.0006139558408279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,40282,156,2.48 [1.85-3.32],1.2941385139796096e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,35749,144,3.39 [2.07-5.57],1.3325659867163593e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,41438,159,2.43 [1.83-3.22],8.583879552618361e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,35066,138,1.58 [1.28-1.96],2.547117818213812e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,40116,153,2.24 [1.80-2.78],2.983451739282145e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35570,141,3.55 [2.49-5.06],2.4491973477181724e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,41022,160,2.66 [1.78-4.00],2.2005900082929115e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,41246,167,2.92 [1.91-4.46],7.105481231369449e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,41546,162,6.87 [4.60-10.27],6.005456929047151e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,41086,162,2.91 [1.76-4.80],2.929109468519308e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,41580,165,7.84 [3.59-17.13],2.345642404017653e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,41580,165,3.25 [2.24-4.73],6.20621403779348e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,35130,140,2.12 [1.46-3.06],6.913193364653091e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,41086,162,2.20 [1.64-2.96],1.2608659213323284e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,41078,162,2.65 [1.71-4.10],1.296941550565734e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,41305,162,3.32 [2.18-5.05],2.092231433768775e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,41086,162,2.65 [1.79-3.92],1.13293695406144e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,41193,165,1.96 [1.62-2.38],4.549589952364442e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35669,140,2.20 [1.69-2.87],5.456462920657157e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,41246,167,1.77 [1.26-2.48],0.0009283374565977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,41119,167,1.97 [1.32-2.94],0.0008803983815157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,41305,162,3.59 [1.95-6.60],4.0338272864151175e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,35655,142,2.31 [1.71-3.10],3.5094362406824365e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,41368,163,3.72 [2.21-6.27],8.347351449317654e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,35669,140,2.99 [1.91-4.66],1.4344538453021216e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,41078,162,3.28 [2.40-4.49],1.2002142054919438e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,35559,140,1.82 [1.32-2.50],0.0002510074875983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,41386,160,1.65 [1.23-2.22],0.0009353380438171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,41078,162,3.79 [2.58-5.58],1.1492515625920198e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34698,142,2.01 [1.56-2.57],4.567455814213077e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,41546,162,2.66 [1.94-3.65],1.051605186626613e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,40567,156,3.44 [2.51-4.73],1.93994925686614e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41086,162,2.43 [1.60-3.68],3.2169593329743684e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,41086,162,2.06 [1.48-2.87],1.73601908815013e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,35725,144,4.81 [2.70-8.59],1.0265287889634945e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,41193,165,4.76 [3.12-7.25],3.9547970065500666e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,41086,162,2.08 [1.67-2.59],3.791375763468199e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,40791,166,3.33 [2.16-5.12],4.957998685454753e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41394,163,5.30 [3.36-8.37],7.541763889111144e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,34698,142,1.66 [1.28-2.14],0.000104951668593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,40347,156,2.25 [1.53-3.31],3.520847398472212e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,41330,164,2.61 [1.96-3.47],3.8147721203187646e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,35655,142,1.77 [1.36-2.32],2.963089365190868e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,41168,160,0.47 [0.33-0.67],2.3315025292634774e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,34698,142,1.82 [1.41-2.35],3.641126427042738e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,40919,166,1.88 [1.38-2.57],6.633033810659376e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,41451,161,3.32 [2.29-4.80],2.1194818666660022e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,40770,158,2.28 [1.60-3.26],5.838659358413903e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,40116,153,1.99 [1.41-2.81],8.380999132250116e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,35570,141,2.05 [1.56-2.69],2.8711631765211815e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35570,141,2.45 [1.51-3.99],0.0003016041594573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,40965,163,2.70 [1.55-4.71],0.0004519547411067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,39933,153,1.85 [1.52-2.24],4.80680563489737e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,41438,159,2.04 [1.47-2.83],2.008483305353014e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,35669,140,1.73 [1.29-2.32],0.0002711584612738
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,34698,142,1.35 [1.14-1.60],0.000408998860899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,35485,142,1.66 [1.23-2.22],0.0007681394249082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,41395,165,2.38 [1.60-3.55],2.10809954945184e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,34777,137,2.05 [1.36-3.07],0.0005547438288843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41119,167,4.83 [3.40-6.85],1.2140629116199813e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,41438,159,3.59 [2.10-6.16],3.3195797648121943e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,39999,153,2.15 [1.47-3.15],8.614345369949114e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,41438,159,3.66 [2.41-5.54],9.375358989080215e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,40341,157,1.66 [1.24-2.22],0.0006200996759628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,41330,161,1.73 [1.33-2.26],4.085778646672528e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,41078,162,2.41 [1.87-3.10],7.759407198301483e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,41078,162,0.56 [0.42-0.75],7.863317958490647e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,35570,141,1.45 [1.21-1.73],3.917131808823149e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,41580,165,2.02 [1.54-2.64],3.515121082504466e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41451,164,4.10 [3.16-5.32],3.716092950517568e-26
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,40676,161,1.57 [1.32-1.87],4.680089977865445e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,35709,144,0.38 [0.22-0.67],0.0007604619978805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,40885,161,3.78 [2.63-5.43],7.661713491175325e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,35730,144,2.28 [1.47-3.52],0.0002207158040374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41246,167,2.23 [1.68-2.97],3.7277701255203495e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,41034,163,3.05 [2.15-4.31],3.152680084890102e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,41451,161,2.03 [1.36-3.01],0.0004895132941043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,41078,162,3.25 [2.13-4.95],4.550599984999727e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,34777,137,1.95 [1.37-2.75],0.0001752820311769
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,40979,167,1.77 [1.33-2.35],7.70085681933039e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,41034,163,1.50 [1.20-1.88],0.0004183060132965
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,40144,155,1.97 [1.51-2.57],5.874172712516494e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,41451,161,1.96 [1.34-2.88],0.0005671594563447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,41229,156,1.84 [1.42-2.37],2.6707090698099827e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,41086,162,1.72 [1.30-2.27],0.0001397506037109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,40955,161,5.48 [4.13-7.27],3.592997926108708e-32
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,41119,167,3.15 [2.30-4.32],1.1771342230050196e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,40895,160,3.56 [2.50-5.07],1.8163283902577944e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,41510,164,2.36 [1.80-3.11],7.08610664766543e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,35725,144,3.85 [2.73-5.43],1.3184176372145916e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,41438,159,1.84 [1.40-2.43],1.407028023103017e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,41034,163,1.66 [1.41-1.96],7.830979969224335e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",35669,140,1.54 [1.25-1.90],5.325544156979818e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,36444,140,2.93 [2.21-3.90],1.2249358202649304e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,41193,165,3.05 [1.68-5.54],0.000248860415818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,41186,167,1.54 [1.24-1.91],0.0001006506450719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,41043,162,1.56 [1.22-1.98],0.0003099225035568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,41066,164,1.59 [1.30-1.93],4.592618159552142e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,41473,162,2.05 [1.54-2.74],1.0568886786975547e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,40834,159,3.91 [2.51-6.11],1.924633901436973e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,41193,165,2.06 [1.45-2.91],4.909981266659225e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,41086,162,3.67 [2.98-4.52],2.9484448470157523e-34
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,41096,160,1.68 [1.25-2.27],0.0006540002977385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,41438,159,2.50 [1.59-3.93],7.857394411501603e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41229,162,2.00 [1.48-2.69],5.6830241578201285e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,40637,161,4.07 [3.16-5.24],1.187957141795933e-27
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,40952,160,3.21 [1.75-5.87],0.0001595848114876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40774,156,2.11 [1.55-2.87],1.6597064333430402e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40774,156,1.41 [1.20-1.65],2.4259034039849884e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41546,162,2.28 [1.69-3.07],7.39136727843985e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41047,167,4.43 [3.08-6.36],8.883117163932782e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41193,165,1.86 [1.31-2.66],0.0006109079596419
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41119,167,2.00 [1.46-2.75],1.930369133879423e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41119,167,2.21 [1.48-3.30],0.000106221635531
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41086,162,2.68 [1.83-3.91],3.703812768839165e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41086,162,1.71 [1.40-2.09],2.0079918094323581e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41438,159,3.65 [2.35-5.68],8.909566379833544e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41473,162,2.04 [1.47-2.83],2.244228906063952e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40774,156,1.62 [1.33-1.99],2.6940798445655363e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40774,156,1.73 [1.28-2.34],0.0003642239996082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,41034,163,0.61 [0.48-0.76],1.8625387127539026e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41510,165,2.64 [1.92-3.63],2.224333487583438e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35730,144,2.68 [1.93-3.73],4.827626810943369e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,40787,166,1.71 [1.35-2.15],6.6955100489045445e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,35570,141,1.51 [1.29-1.75],1.4996161958095501e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,35389,143,0.45 [0.30-0.67],7.939753134828854e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,41193,165,2.65 [1.71-4.11],1.2640622584448049e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,40774,156,2.36 [1.72-3.24],1.0236185562601593e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,40347,156,1.61 [1.38-1.87],1.542354214801676e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41168,160,5.46 [3.84-7.76],3.150431924569957e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,40144,155,2.29 [1.59-3.29],8.048733320099961e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,41580,165,1.38 [1.15-1.66],0.0005144991084538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,38976,152,1.74 [1.27-2.38],0.0005181921276636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40644,155,0.56 [0.40-0.79],0.0008429031411341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,35655,142,2.31 [1.49-3.56],0.0001602546973844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,40347,156,1.54 [1.21-1.96],0.0004310722678453
